The world of small-cap health care investing is one of huge booms and major busts. However, equities.com's Small-Cap Stars, our proprietary list of small-cap companies with characteristics we've found to be most predictive of future success, helps you find those companies with a strong foundation that are best positioned to capitalize on future success.
Here are today's top-performing health care Small-Cap Stars as of noon on the east coast:
Boston Therapeutics Inc (BTHE)
Boston Therapeutics Inc gained 11.11% to $0.50 in morning trading today. Volume reached 9,220 by noon. The stock's average daily volume is 29,651 shares. Boston Therapeutics Inc has a 52-week high of $1.67 and a 52-week low of $0.15, and its 50-day SMA and 200-day SMA are $0.55 and $0.90 respectively.
Boston Therapeutics Inc is engaged in developing, manufacturing and commercializing of therapeutic drugs with a focus on complex carbohydrate chemistry to address diabetes and inflammatory diseases.
Insys Therapeutics Inc (INSY)
Insys Therapeutics Inc gained 9.62% to $30.98 in morning trading today. Volume reached 589,370 by noon. The stock's average daily volume is 515,990 shares. Insys Therapeutics Inc has a 52-week high of $57.91 and a 52-week low of $11.49, its P/E ratio is 20.2, and its 50-day SMA and 200-day SMA are $27.61 and $32.85 respectively.
Insys Therapeutics, Inc is a commercial-stage specialty pharmaceutical company. It develops and commercializes supportive care products that target the unmet needs of cancer patients, with an initial focus on cancer supportive care.
Repligen Corporation (RGEN)
Repligen Corporation gained 6.48% to $22.67 in morning trading today. Volume reached 190,017 by noon. The stock's average daily volume is 389,183 shares. Repligen Corporation has a 52-week high of $24.68 and a 52-week low of $9.41, its P/E ratio is 38.6, and its 50-day SMA and 200-day SMA are $21.82 and $16.13 respectively.
Repligen Corp is a life sciences company engaged in the development, manufacture & sale of consumable bioprocessing products for life sciences companies & biopharmaceutical manufacturing companies. It also supplies growth factor products.
Vanda Pharmaceuticals Inc. (VNDA)
Vanda Pharmaceuticals Inc. gained 6.05% to $12.79 in morning trading today. Volume reached 562,308 by noon. The stock's average daily volume is 590,706 shares. Vanda Pharmaceuticals Inc. has a 52-week high of $19.25 and a 52-week low of $5.70, and its 50-day SMA and 200-day SMA are $14.11 and $12.94 respectively.
Vanda Pharmaceuticals, Inc. is a biopharmaceutical company engaged in the development and commercialization of products for the treatment of central nervous system disorders such as HETLIOZ, Fanapt and VLY-686.
Athersys Inc. (ATHX)
Athersys Inc. gained 5.81% to $1.64 in morning trading today. Volume reached 145,835 by noon. The stock's average daily volume is 374,921 shares. Athersys Inc. has a 52-week high of $4.33 and a 52-week low of $1.08, and its 50-day SMA and 200-day SMA are $1.66 and $2.45 respectively.
Athersys Inc is a biopharmaceutical company developing regenerative medicine. It is engaged in the discovery and development of therapies designed to extend and enhance human life.
Equities.com's Health Care Small-Cap Stars - Helping You Build a Healthier Portfolio
There's no crystal ball that will tell you what the outcome of this or that clinical trial is going to be. Even if there were, the one astonishingly wealthy person who owns it probably wouldn't share. But that doesn't mean that investing in the right small-cap health care companies can't pay dividends in the long term. While the future of a company's lead therapy may not be certain, most of its present fundamentals are. And while investing in the small-cap biotech market will always be hit-or-miss, investing in solidly built players should help boost that batting average.
Our Small-Cap Stars system uses a complex statistical regression to isolate those fundamental factors that previous success stories had in common and then identifies those small caps that are the most similar to that profile in the present.
For health care companies, we found that a high enterprise value, a strong value line beta, and a high rate of reinvestment were among the most indicative of a small-cap company's potential for success.
All data provided by QuoteMedia and was accurate as of 12:00 pm ET.